Reaction

Vocal Cord Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,952 reports · 31 co-occurring drugs

As of the last recalculation, Vocal Cord Disorder appears in 1,952 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 13.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Salmeterol Xinafoate	11	13.7	13.7
Tiotropium Bromide Inhalation Spray	13	12.4	12.5
Ciclesonide	15	11.8	11.8
Budesonide And Formoterol Fumarate Dihydrate	101	11.6	11.7
Fluticasone Propionate And Salmeterol	42	11.0	11.0
Budesonide, Glycopyrrolate, And Formoterol Fumarate	10	10.3	10.3
Rocuronium Bromide	11	10.0	10.0
Fluticasone Propionate And Salmeterol Xinafoate	48	8.7	8.7
Thyroid, Porcine	8	8.0	8.0
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	15	7.8	7.8
Naproxen Sodium, Pseudoephedrine Hydrochloride	15	7.8	7.8
Fluticasone Furoate And Vilanterol Trifenatate	26	7.8	7.8
Sevoflurane	6	7.7	7.7
Tiotropium Bromide	77	6.2	6.2
Nintedanib	17	5.8	5.8
Armodafinil	11	5.6	5.6
Mometasone Furoate And Formoterol Fumarate Dihydrate	8	5.5	5.5
Tobramycin	12	5.3	5.3
Omalizumab	41	5.2	5.2
Crizotinib	6	5.0	5.0
Brimonidine Tartrate	8	4.8	4.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	18	4.7	4.7
Axitinib	7	3.8	3.8
Umeclidinium Bromide And Vilanterol Trifenatate	6	3.8	3.8
Sodium Oxybate	23	3.8	3.8
Benralizumab	7	3.7	3.7
Tafamidis	4	3.6	3.6
Ledipasvir And Sofosbuvir	6	3.3	3.3
Onabotulinumtoxina	22	3.1	3.1
Lifitegrast	4	2.6	2.6
Osimertinib	7	2.3	2.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.